IBRNvsLDSF
iShares Neuroscience and Healthcare ETF against FIRST TRUST LOW DURATION STRATEGIC FOCUS ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | LDSF | |
|---|---|---|
| Expense ratio | 0.47% | — |
| Assets | $7931.50T | $153M |
| Net flow, 1 month | +$2M | — |
| Net flow, 1 year | +$2M | — |
| Return, YTD | +27.9% | -1.2% |
| Return, 1 year | +68.6% | -0.8% |
| Avg daily volume | 3K | 23K |
| Holdings | 54 | 6 |
| Listed | Aug 23, 2022 | Jun 14, 2024 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS